Last reviewed · How we verify

NCT05142917

The Effect of tDCS Based on Functional Brain Imaging for Subacute Stroke Patients

Completed NA Last updated 1 March 2023
What this trial tests

NA trial testing Transcranial Direct Current Stimulation in Stroke in 12 participants. Completed in 8 January 2023.

Timeline
11 February 2022
Primary endpoint
8 January 2023
8 January 2023

Quick facts

Lead sponsorSamsung Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment12
Start date11 February 2022
Primary completion8 January 2023
Estimated completion8 January 2023
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Samsung Medical Center

Who can join

Adults 19 to 80, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate whether brain imaging-based hand function area tDCS stimulation is more effective than conventional stimulation or sham stimulation for improving hand motor function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Transcranial Direct Current Stimulation

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Samsung Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05142917.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing